// App-Quantinova.ai

ES12-2 : Targeted DNA repair in cancer and new NUDT5 inhibitors to block hormone signalling to target breast cancer

Researchers

Presenter

  • Helleday, T

Principal Investigators

  • N/A

Medical Centers

  • University of Sheffield, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • BRCA mutation

Drug/Treatment

  • Progestin

  • CycloGest

  • ribose

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved